Skip to main content
. 2022 Oct 6;14(1):2128603. doi: 10.1080/19490976.2022.2128603

Figure 1.

Figure 1.

Antibiotic-naive COVID-19 patients harbor more ARGs than non-COVID-19 controls. (a) Schematic overview of the study design, depicting the total number of samples and participants from whom data were available. The horizontal bars represent the sample collected at specific time point from antibiotic-naive COVID-19 patients. (b) Bray–Curtis-based beta diversity of baseline stool samples from COVID-19 patients and non-COVID-19 subjects based on ARG subtypes. The alpha diversity (Shannon, C), observed ARG types (d), observed ARG subtypes (e), and the normalized abundance of ARGs (f) were all significantly higher in stool samples from COVID-19 patients than that of non-COVID-19 subjects. (g) The prevalence of ARG types in COVID-19 patients and non-COVID-19 subjects.